Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Revenue
Aslan Pharmaceuticals Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Revenue
$12m
|
CAGR 3-Years
59%
|
CAGR 5-Years
231%
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Revenue?
Revenue
12m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Revenue amounts to 12m USD.
What is Aslan Pharmaceuticals Ltd's Revenue growth rate?
Revenue CAGR 5Y
231%
The average annual Revenue growth rates for Aslan Pharmaceuticals Ltd have been 59% over the past three years , 231% over the past five years .